Searched over 200M research papers
10 papers analyzed
Some studies suggest magnesium supplementation can significantly lower blood pressure, especially in specific populations or with higher doses, while other studies indicate it may not be effective in unselected or mild hypertensive subjects.
20 papers analyzed
Magnesium is an essential mineral involved in numerous physiological processes, including muscle function, nerve transmission, and blood pressure regulation. The relationship between magnesium intake and blood pressure has been a subject of extensive research, with varying conclusions. This article synthesizes findings from multiple studies to provide a clear understanding of the effects of magnesium supplementation on high blood pressure.
Several studies have found that magnesium supplementation does not significantly affect blood pressure. For instance, a double-blind study involving 17 patients with mild to moderate hypertension showed no reduction in blood pressure despite increased plasma magnesium levels and urinary excretion. Similarly, the Trials of Hypertension Prevention (TOHP) Phase I study, which included 698 adults with high-normal diastolic blood pressure, found no significant changes in blood pressure after magnesium supplementation. Another study involving 71 subjects with mild hypertension or high-normal blood pressure also reported no general effects on blood pressure from magnesium supplementation.
Contrary to the individual studies, meta-analyses have shown more promising results. A meta-analysis of 34 trials involving 2028 participants found that magnesium supplementation at a median dose of 368 mg/day for three months significantly reduced systolic blood pressure by 2.00 mm Hg and diastolic blood pressure by 1.78 mm Hg. Another meta-analysis of 22 trials with 1173 participants reported a reduction in systolic blood pressure by 3-4 mm Hg and diastolic blood pressure by 2-3 mm Hg, with greater effects observed in crossover trials and higher magnesium doses. Additionally, a meta-analysis focusing on individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases found that magnesium supplementation resulted in a mean reduction of 4.18 mm Hg in systolic blood pressure and 2.27 mm Hg in diastolic blood pressure.
The effectiveness of magnesium supplementation appears to be dose-dependent. Higher doses of magnesium, such as those exceeding 370 mg/day, have been associated with more significant reductions in blood pressure . The duration of supplementation also plays a role, with longer treatment periods generally yielding better results .
Baseline magnesium status may influence the response to supplementation. One study found that individuals with lower pretreatment urinary magnesium excretion experienced a reduction in blood pressure, while those with higher baseline levels did not benefit as much. This suggests that magnesium supplementation may be more effective in individuals with an existing deficiency.
The combination of magnesium with other minerals, such as potassium and reduced sodium, has shown beneficial effects on blood pressure. A study involving older adults with mild to moderate hypertension found that a low sodium, high potassium, and high magnesium salt significantly reduced both systolic and diastolic blood pressure.
The impact of magnesium on high blood pressure is complex and influenced by various factors, including dosage, duration, baseline magnesium status, and combined mineral intake. While individual studies have shown mixed results, meta-analyses suggest that magnesium supplementation can lead to modest but clinically significant reductions in blood pressure. Further well-designed trials are needed to confirm these findings and determine the optimal conditions for magnesium supplementation to effectively manage high blood pressure.
Most relevant research papers on this topic